Century Therapeutics (IPSC) FCF Margin (2022 - 2025)

Century Therapeutics' (IPSC) quarterly FCF Margin came in at 32.15% in Q1 2025, up 356867.0% year-on-year from N/an in Q1 2024, and up 94.46% on a QoQ basis from 580.47% in Q4 2024.

Century Therapeutics (IPSC) FCF Margin (2022 - 2025) Analysis & Trends

Century Therapeutics (IPSC) has 4 years of FCF Margin data on file, last reported at 32.15% in Q1 2025.

  • On a quarterly basis, FCF Margin rose 356867.0% year-over-year to 32.15% in Q1 2025; TTM through Dec 2025 was 95.95%, a 158749.0% increase from a year earlier, with the FY2025 full-year figure at 95.95%, up 157788.0% from the prior year.
  • FCF Margin for Q1 2025 stood at 32.15%, up from 580.47% in the prior quarter.
  • Over the last five years, FCF Margin for IPSC reached as high as 7815.31% in Q1 2022 and fell as low as 23989.9% in Q2 2023.
  • Historically, FCF Margin has averaged 4266.57% across 4 years, with a median of 2579.73% in 2022.
  • Across the five-year window, FCF Margin tumbled 2141017 bps in 2023 and soared 2041052 bps in 2024, its largest moves.
  • Year by year, FCF Margin stood at 235.12% in 2022, then tumbled by 4218 bps to 10152.99% in 2023, then surged by 94 bps to 580.47% in 2024, then jumped by 94 bps to 32.15% in 2025.
  • Per Business Quant data, the three most recent FCF Margin figures were 32.15% in Q1 2025, 580.47% in Q4 2024, and 3581.8% in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Century Therapeutics 419.84 Mn 285.04 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -32.15%
Dec 31, 2024 -580.47%
Sep 30, 2024 -3,581.80%
Jun 30, 2024 -3,579.38%
Mar 31, 2024 -3,600.82%
Dec 31, 2023 -10,152.99%
Sep 30, 2023 -11,428.38%
Jun 30, 2023 -23,989.90%
Mar 31, 2023 -1,988.95%
Dec 31, 2022 -235.12%
Sep 30, 2022 -1,531.03%
Jun 30, 2022 -2,579.73%
Mar 31, 2022 7,815.31%